University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven


Hospital

Location:
Leuven, etc., Belgium


Publications in cooperation with FAU scientists


Go to first page Go to previous page 1 of 5 Go to next page Go to last page
Ebert, D., Berking, M., Kählke, F., Bruffaerts, R., Baumeister, H., Auerbach, R.P.,... Kessler, R.C. (2019). Barriers of mental health treatment utilization among first-year college students: First cross-national results from the WHO World Mental Health International College Student Initiative. International Journal of Methods in Psychiatric Research, 28(2). https://dx.doi.org/10.1002/mpr.1782
Burgmaier, K., Kilian, S., Bammens, B., Benzing, T., Billing, H., Buescher, A.,... Liebau, M.C. (2019). Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD). Scientific Reports, 9(1), 7919-. https://dx.doi.org/10.1038/s41598-019-43488-w
Konrad, E., Nardini, N., Caliebe, A., Nagel, I., Young, D., Horvath, G.,... Zweier, C. (2019). CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum. Genetics in Medicine. https://dx.doi.org/10.1038/s41436-019-0585-z
Diener, H.C., Sacco, R.L., Donald Easton, J., Granger, C.B., Bernstein, R.A., Uchiyama, S.,... Toyoda, K. (2019). Dabigatran for prevention of stroke after embolic stroke of undetermined source. New England Journal of Medicine, 380(20), 1906-1917. https://dx.doi.org/10.1056/NEJMoa1813959
Dalekos, G., Invernizzi, P., Nevens, F., Hans, V.V., Zigmond, E., Andrade, R.J.,... Wiese, P. (2019). Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. In JOURNAL OF HEPATOLOGY (pp. E1-E2). Vienna, AUSTRIA: AMSTERDAM: ELSEVIER SCIENCE BV.
Yao, J., Garg, A., Chen, D., Capdevila, J., Engstrom, P., Pommier, R.,... Kulke, M.H. (2019). Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials. Endocrine-Related Cancer, 26(4), 391-403. https://dx.doi.org/10.1530/ERC-18-0332
Stone, J.H., Bao, M., Han, J., Aringer, M., Blockmans, D., Brouwer, E.,... Unizony, S. (2019). LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ARTERITIS: RESULTS FROM PART 2 OF THE GIACTA TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 145-146). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Auerbach, R.P., Mortier, P., Bruffaerts, R., Alonso, J., Benjet, C., Cuijpers, P.,... Kessler, R.C. (2019). Mental disorder comorbidity and suicidal thoughts and behaviors in the World Health Organization World Mental Health Surveys International College Student initiative. International Journal of Methods in Psychiatric Research, 28(2). https://dx.doi.org/10.1002/mpr.1752
Subramaniam, S., Hayee, B., Aepli, P., Schoon, E., Stefanovic, M., Kandiah, K.,... Bhandari, P. (2019). Optical diagnosis of colorectal polyps with Blue Light Imaging using a new international classification. United European Gastroenterology Journal, 7(2), 316-325. https://dx.doi.org/10.1177/2050640618822402
Alonso, J., Vilagut, G., Mortier, P., Auerbach, R.P., Bruffaerts, R., Cuijpers, P.,... Kessler, R.C. (2019). The role impairment associated with mental disorder risk profiles in the WHO World Mental Health International College Student Initiative. International Journal of Methods in Psychiatric Research, 28(2). https://dx.doi.org/10.1002/mpr.1750
Stone, J.H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D.,... Collinson, N. (2018). ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL. (pp. 1120-1121).
Wilkinson, M., Gallo, R., Goossens, A., Johansen, J.D., Rustemeyer, T., Sanchez-Perez, J.,... Uter, W. (2018). A proposal to create an extension to the European baseline series. Contact Dermatitis, 78(2), 101-108. https://dx.doi.org/10.1111/cod.12918
Beziat, V., Li, J., Lin, J.-X., Ma, C.S., Li, P., Bousfiha, A.,... Casanova, J.-L. (2018). A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Science immunology, 3(24). https://dx.doi.org/10.1126/sciimmunol.aat4956
Strnad, V., Major, T., Polgar, C., Lotter, M., Guinot, J.-L., Gutierrez-Miguelez, C.,... Hannoun-Levi, J.-M. (2018). ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations. Radiotherapy and Oncology, 128(3), 411-420. https://dx.doi.org/10.1016/j.radonc.2018.04.009
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05427-7
Hurvitz, S.A., Martin, M., Symmans, W.F., Jung, K.H., Huang, C.-S., Thompson, A.M.,... Slamon, D. (2018). Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncology, 19(1), 115-126. https://dx.doi.org/10.1016/S1470-2045(17)30716-7
Fasching, P., Esteva, F.J., Pivot, X., Nusch, A., Beck, J.T., Chan, A.,... Neven, P. (2018). Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib plus fulvestrant: Results from MONALEESA-3. In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
Feagan, B.G., Panes, J., Ferrante, M., Kaser, A., D'Haens, G.R., Sandborn, W.J.,... Boecher, W.O. (2018). Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study. Lancet Gastroenterology and Hepatology, 3(10), 671-680. https://dx.doi.org/10.1016/S2468-1253(18)30233-4
Kelemen, L.E., Earp, M., Fridley, B.L., Chenevix-Trench, G., Fasching, P., Beckmann, M.,... Berchuck, A. (2018). rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences, 19(9). https://dx.doi.org/10.3390/ijms19092473
Lee, M., Wlodarczak, A., Bennett, J., Torzewski, J., Haude, M., Vrolix, M.,... Verheye, S. (2018). Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First 400 Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry. (pp. B142-B143).

Last updated on 2016-10-05 at 08:26